Bone Cysts - 25 Studies Found Enrolling by invitation : Osteoconduction Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects : Grafting, Bone : 2005-09-12 : Device: MBCP-Gel (tm) Completed : Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face : Neoplastic Syndrome : 2007-06-20 : Drug: tazarotene Tazarotene is a member of the acetylenic class of retinoids. Completed : Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back : Skin Carcinoma : 2008-10-31 : Drug: tazarotene Applied to th Withdrawn : Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) : Basal Cell Carcinoma : 2010-07-06 : Drug: LDE225B Cream, 2x daily Recruiting : Familial Investigations of Childhood Cancer Predisposition : Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin : 2017-02-08 Completed : Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients : Basal Cell Nevus Syndrome : 2016-04-27 : Drug: patidegib patidegib gel Recruiting : Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas : Basal Cell Carcinoma : 2015-12-14 : Drug: Vismodegib Vismodegib 150 mgs po qd for 3 months Recruiting : A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma : Basal Cell Nevus Syndrome Skin Neoplasm Nodular Basal Cell : 2015-09-10 : Biological: ASN-002 ASN‐ Recruiting : Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) : Basal Cell Carcinoma in Basal Cell Nevus Syndrome : 2015-01-21 : Drug: SUBA-Itraconazole Subjects will receive an oral dose of 300 mg SUBA-Itraconazole daily. Active, not recruiting : Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma : Basal Cell Carcinoma of the Skin Nevoid Basal Cell Carcinoma Syndrome Drug: Buparlisib Given PO <<< Previous | Next >>>